N/A
Manufactured by Wal-Mart Stores Inc
6 FDA adverse event reports analyzed
Last updated: 2026-04-15
ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Wal-Mart Stores Inc. The most commonly reported adverse reactions for ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL include BLOOD SODIUM DECREASED, CARDIO-RESPIRATORY ARREST, COMPLETED SUICIDE, DEATH, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL.
Out of 2 classified reports for ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 6 FDA FAERS reports that mention ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include BLOOD SODIUM DECREASED, CARDIO-RESPIRATORY ARREST, COMPLETED SUICIDE, DEATH, DIZZINESS, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Wal-Mart Stores Inc in connection with ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL. Always verify the specific product and NDC with your pharmacist.